📰 Ghost Cytometry News
Page 2 - Ghost Cytometry News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ghost Cytometry. Real-time updates on events, politics, business and more.
June 23, 2022
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering Ghost Cytometry, a proprietary AI-based, label-free cell sorting technology, today announced...
June 23, 2022
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering Ghost Cytometry, a proprietary AI-based, label-free cell sorting technology, today announced...
April 28, 2022
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
May 19, 2021
The companies will develop a solution based on a new technique of flow cytometry that enables fast and accurate cell analysis using AI.
May 19, 2021
Photo by dowell/Getty Images Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte for the production and sale of a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics. WHAT ITS FOR Sysmex has been acquiring technologies for analysing cells, genes, and proteins with a high degree of precision and sensitivity. It chose to collaborate with ThinkCyte as it poss...
May 19, 2021
ThinkCyte Secures $26 million in Series B Financing Funding will be used to advance the development of AI-based cell analysis and sorting platforms in cell therapy and diagnostics. News provided by Share this article Share this article TOKYO, May 19, 2021 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing, led by SPARX Group ...
May 12, 2021
Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance - Commencing development of novel AI-based cell analyzers and testing techniques - News provided by Share this article Share this article TOKYO, May 12, 2021 /PRNewswire/ -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and ThinkCyte, Inc. (HQ: Bunkyo-ku, Tokyo, Japan; CEO: Waichiro Katsuda) announced today the signing of joint development and investment agreements during May 2021 for the commercializ...